- Nachrichtendetail
-
12.07.2024 14:33:04 - dpa-AFX: *ABBVIE SEEKS FDA AND EMA APPROVAL FOR UPADACITINIB IN GIANT CELL ARTERITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ABBVIE INC. DL-,01 | A1J84E | Frankfurt | 176,800 | 15.08.24 15:36:32 | +3,620 | +2,09% | 174,740 | 175,280 | 174,680 | 173,180 |
